(Q42579409)

3 November 2017

Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid (English)

1 reference

multidrug-resistant tuberculosis

3 November 2017

1 reference

multiple drug resistance

1 reference

based on heuristic

inferred from title

1 reference

Charles D Wells

1

1 reference

3 November 2017

Rajesh Gupta

series ordinal

2

1 reference

3 November 2017

Norbert Hittel

series ordinal

3

1 reference

3 November 2017

Lawrence J Geiter

series ordinal

4

1 reference

3 November 2017

language of work or name

1 reference

19 February 2015

1 reference

European Respiratory Journal

3 November 2017

1 reference

3 November 2017

45

1 reference

3 November 2017

5

1 reference

3 November 2017

1498-1501

1 reference

Delamanid: first global approval

3 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416109

Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416109

Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416109

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416109

Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416109

Delamanid for multidrug-resistant pulmonary tuberculosis

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416109

New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the future

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416109

Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416109

Antimicrobial therapy of tuberculosis: justification for currently recommended treatment regimens

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416109

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416109

Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome

1 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25700385

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25700385

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1183/09031936.00176314

1 reference

3 November 2017

1 reference

3 November 2017

PubMed publication ID

25700385

1 reference